Trial Profile
An observational study to evaluate the efficacy of Methoxy polyethylene glycol-epoetin-beta in haemodialysis dependent or non-dialysis dependent patients with chronic kidney disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Mar 2016
Price :
$35
*
At a glance
- Drugs Methoxy polyethylene glycol-epoetin beta (Primary)
- Indications Anaemia
- Focus Adverse reactions; Therapeutic Use
- 03 Mar 2016 New trial record